Advertisement

A perfused vein preparation sensitive to plasma kinins

  • J. D. Horowitz
  • M. L. Mashford
Article

Summary

The isolated perfused central vein of the rabbit ear constricts in response to approximately 0.5 ng of BK or kallidin injected into the perfusion flow of 10 ml/min. Constrictor responses are also elicited by several other substances including catecholamines and histamine but none approach the potency of the plasma kinins. This relative specificity together with the steep dose-response curve for kinins makes it an eminently suitable preparation for bioassay of these peptides. Rabbit veins from other sites do not have the same pattern of reactivity and no generalization is possible from these data to veins in vivo.

Key-Words

Veins Plasma Kinins 

Schlüsselwörter

Venen Plasmakinin 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bobbin, R. P., and P. S. Guth: Venoconstrictive action of bradykinin. J. Pharmacol. exp. Ther. 160, 11–21 (1968).Google Scholar
  2. Chou, C. C., E. D. Frohlich, and E. C. Texter Jr.: A comparative study of the effects of bradykinin, kallidin II and eledoisin on segmental superior mesenteric resistance. J. Physiol. (Lond.) 176, 1–11 (1965).Google Scholar
  3. de la Lande, I. S., and M. J. Rand: A simple isolated nerve-blood vessel preparation. Aust. J. exp. Biol. med. Sci. 43, 639–656 (1965).Google Scholar
  4. Florey, H. W., and H. M. Carleton: Rouget cells and their functions. Proc. roy. Soc. B 100, 23–31 (1926).Google Scholar
  5. Greeff, K., u. E. Moog: Vergleichende Untersuchungen über die Bronchoconstrictorische Wirkung des Bradykinin, Histamins und Serotonins an isolierten Lungen präparation. Naunyn-Schmiedebergs Arch. exp. Path. Pharmak. 248, 204–215 (1964).Google Scholar
  6. Guth, P. S., R. Bobbin, G. Cano, and J. Amaro: Venoconstriction induced by bradykinin in the intact and denervated rabbit ear. Fed. Proc. 25, 287 (1966).Google Scholar
  7. ——, and J. Jaramillo: The effect of bradykinin on vascular smooth muscle. Ann. N. Y. Acad. Sci. 104, 69–76 (1963).Google Scholar
  8. Horowitz, J. D., and M. L. Mashford: Vasoactivity of human plasma and plasma protein fractions. Experientia (Basel) 24, 1126 (1968).Google Scholar
  9. Klupp, H., u. H. Konzett: Der Einfluß von Bradykinin und Kallidin auf dem Druck in der Arteria pulmonalis. Naunyn-Schmiedebergs Arch. exp. Path. Pharmak. 249, 479–485 (1965).Google Scholar
  10. Rowley, D. A.: Venous constriction as the cause of increased vascular permeability produced by 5-hydroxytryptamine, histamine, bradykinin and 48/80 in the rat. Brit. J. exp. Path. 45, 56–67 (1964).Google Scholar
  11. Sakuma, A., and S. Oh-Ishi: Tranexamic acid enhances bradykinin induced venoconstriction. Jap. J. Pharmacol. 16, 485–486 (1966).Google Scholar
  12. Wiegershausen, B., u. G. Hennighausen: Gefäßkonstriktion durch synthetisches Bradykinin und ihre pharmakologische Beeinflußbarkeit. Experientia (Basel) 22, 234–235 (1966).Google Scholar
  13. Zacest, R., and M. L. Mashford: Blood bradykinin levels in the human. Aust. J. exp. Biol. med. Sci. 45, 89–95 (1967).Google Scholar

Copyright information

© Springer-Verlag 1969

Authors and Affiliations

  • J. D. Horowitz
    • 1
  • M. L. Mashford
    • 1
    • 2
  1. 1.Department of Human Physiology and PharmacologyUniversity of Adelaide
  2. 2.Department of Medicine Austin NospitalUniversity of MelbourneHeidelbergAustralia

Personalised recommendations